.25mg of semaglutide Oral Wegovy approved for obesity management by FDA on December 23, 2025 Formulation: High‑dose oral (25 mg daily) — previously only available as weekly injections. Indication: Adults with obesity (BMI ≥30) POLL: What's causing the spike

Beyotime Institute of Biotechnology, Shanghai, China) staining was used to detect the ROS generation in situ

The medication works through multiple mechanisms: it increases satiety signals to your brain, reduces hunger hormones (especially ghrelin), and slows gastric emptying so you feel fuller longer

10.1111/dom.12591 [DOI] [PMC free article] [PubMed] [Google Scholar] 14.Shyangdan DS, Royle P, Clar C, et al

First and foremost, your Functional Medicine practitioner will take blood samples

This article examines the evidence, explores alternative explanations, and provides guidance on managing symptoms and when to seek medical advice